Efficacy of a Novel Zigzag Application Pattern for Micropulse Transscleral Cyclophotocoagulation for the Management of Glaucoma

被引:0
|
作者
Sami, Ahmed [1 ,3 ]
Aboulnasr, Tarek T. [2 ]
El-Shahed, Ahmed F. [1 ]
机构
[1] Helwan Univ, Fac Med, Cairo, Egypt
[2] Benha Univ, Fac Med, Cairo, Egypt
[3] Helwan Univ, Fac Med, Mokattam City Sq, Cairo 11571, Egypt
关键词
cyclophotocoagulation; laser treatment; refractory glaucoma; micropulse; zigzag; OUTCOMES;
D O I
10.1097/IJG.0000000000002095
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis:A zigzag mode of application effectively lowered IOP in glaucoma patients at 6 months with a low incidence of complications despite the longer application time. Comparative studies to assess the potential advantages of treating a larger area of ciliary body with this approach are needed. Purpose:The purpose of this study is to evaluate the clinical outcome of micropulse transscleral laser cyclophotocoagulation with zigzag mode of application in adult glaucomatous patients. Subjects and Methods:A prospective single-arm clinical trial included a series of 34 eyes of 30 consecutive patients who underwent micropulse transscleral cyclophotocoagulation (MP-TSCPC) with zigzag technique at a private ophthalmology center. The trial was conducted from March 16, 2021 to April 12, 2021. Patients who had at least 6 months of follow-up were included. MP-TSCPC probe was moved for 2 mm perpendicular to a line 3 mm parallel to the cornea. This aims to cover the largest circumference of the area supposed to hinder the cilliary body. The probe is moved over 3 quadrants for 90 seconds for each quadrant (total 270 s). Defined as an intraocular pressure (IOP) of 6 to 21 mm Hg or a reduction of IOP by 30%. Failure was defined as an inability to meet the criteria for success or need for retreatment. Results:The mean age of involved patients was 52.9 (& PLUSMN;SD: 3.9) years old. The mean IOP before MP-TSCPC was 37.47 (& PLUSMN;SD: 11.08) mm Hg, which was significantly reduced to 17.7 (& PLUSMN;SD: 7.4) mm Hg in the last follow-up visit at 6 months. Number of medications showed significant reduction from mean 3.44 (& PLUSMN;SD: 0.99) to 1.91 (& PLUSMN;SD: 1.26) in the last follow-up. Success rate was found to be 88% (30 out of 34 eyes) at the final follow-up, where 9 cases showed complete success (26.5%), whereas 21 (61.8%) cases showed qualified success. Despite the relatively higher parameters used in our study, no cases reported postoperative complications apart from only 1 case of reduced visual acuity by 1 line. Conclusions:A zigzag mode of application effectively lowered IOP in glaucoma patients at 6 months with a low incidence of complications despite the longer application time. Comparative studies to assess the potential advantages of treating a larger area of ciliary body with this approach are needed.
引用
收藏
页码:382 / 388
页数:7
相关论文
共 50 条
  • [1] Efficacy, Safety, and Retreatment Benefit of Micropulse Transscleral Cyclophotocoagulation in Glaucoma
    Chamard, Chloe
    Bachouchi, Alex
    Daien, Vincent
    Villain, Max
    JOURNAL OF GLAUCOMA, 2021, 30 (09) : 781 - 788
  • [2] Clinical Efficacy and Safety Profile of Micropulse Transscleral Cyclophotocoagulation in Advanced Glaucoma
    Williams, Alice
    Moster, Marlene
    Rahmatnejad, Kamran
    Reynolds, Michael
    Horan, Teresa
    Waisbourd, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [3] Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation
    de Vries, Victor A.
    Pals, Jan
    Poelman, Huub J.
    Rostamzad, Parinaz
    Wolfs, Roger C. W.
    Ramdas, Wishal D.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [4] Clinical Efficacy and Safety Profile of Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma
    Williams, Alice L.
    Moster, Marlene R.
    Rahmatnejad, Kamran
    Resende, Arthur F.
    Horan, Teresa
    Reynolds, Michael
    Yung, Edward
    Abramowitz, Benjamin
    Kuchar, Sarah
    Waisbourd, Michael
    JOURNAL OF GLAUCOMA, 2018, 27 (05) : 445 - 449
  • [5] Micropulse Transscleral Cyclophotocoagulation Results in Secondary Glaucoma
    Szilagyi, Zsuzsa
    Kranitz, Kinga
    Nagy, Zoltan Zsolt
    Recsan, Zsuzsa
    LIFE-BASEL, 2023, 13 (05):
  • [6] Efficacy and Safety of Repeated Micropulse Transscleral Diode Cyclophotocoagulation in Advanced Glaucoma
    Lim, Edward J. Y.
    Aquino, Cecilia M.
    Lun, Katherine W. X.
    Lim, Dawn K. A.
    Sng, Chelvin
    Loon, Seng Chee
    Chew, Paul T. K.
    Koh, Victor T. C.
    JOURNAL OF GLAUCOMA, 2021, 30 (07) : 566 - 574
  • [7] Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation Use in Refractory Glaucoma Patients
    Gustianty, Elsa
    Prahasta, Andika
    Rifada, R. Maula
    Tjokrovonco, Ludwig Melino
    MAJALAH KEDOKTERAN BANDUNG, 2022, 54 (03): : 166 - 171
  • [8] Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uveitic Glaucoma
    Xia, Julia L.
    Ertel, Monica K.
    Reddy, Amit K.
    Palestine, Alan G.
    Stanley, Arthur J.
    Young, Cara E. Capitena
    Pantcheva, Mina B.
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (09) : 2495 - 2503
  • [9] Micropulse Transscleral Cyclophotocoagulation for Glaucoma after Penetrating Keratoplasty
    Zemba, Mihail
    Dumitrescu, Otilia-Maria
    Stamate, Alina-Cristina
    Barac, Ileana Ramona
    Tataru, Calin Petru
    Branisteanu, Daniel Constantin
    DIAGNOSTICS, 2022, 12 (05)
  • [10] Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma
    Nguyen, Alexander T.
    Maslin, Jessica
    Noecker, Robert J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (04) : 700 - 705